GILD

Gilead Sciences Inc (GILD)

US
$ 97.88-4.78%

Price Chart

Key Statistics

Market Cap
$ 128B
P/E Ratio
21.60
Revenue (TTM)
$ 28.74B
Volume
11.29M
52W High
$ 119.12
52W Low
$ 59.82
Dividend Yield
3.07%
Beta
0.28

Technicals

50-Day MA
108.9396
200-Day MA
92.7137
52 Week High
119.1239
52 Week Low
59.8241

About GILD

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Employees
17600
Headquarters
Foster City, CA
CEO
Mr. Daniel P. O'Day

Latest News

Environment, Social and Governance (ESG) Risk Ratings

Total ESG Risk Score
22.15
Percentile: 30.98
Environmental Risk Score
0.53
Percentile: 2
Social Risk Score
12.97
Percentile: 2
Governance Risk Score
7.65
Percentile: 2

Controversy Level

ESG data provided by Sustainalytics, Inc.

GILD
Category Average
2Moderate Controversy Level
NoneSevere

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
TOVX
Theriva Biologics I...
$ 2.00
47.07
GPUS
Hyperscale Data Inc...
$ 6.48
37.87
PRCH
Porch Group Inc. Co...
$ 8.05
26.95
CRL
Charles River Labor...
$ 137.99
19.65
REZI
Resideo Technologie...
$ 20.30
16.27

Top Losers

Symbol/Name
LTP
% Chg
NCEW
New Century Logisti...
$ 1.38
-38.12
MLGO
MicroAlgo Inc. Ordi...
$ 2.53
-28.13
IBO
IBO (Listing Market...
$ 0.51
-16.33
FTNT
Fortinet Inc. Commo...
$ 93.20
-13.03
CLF
Cleveland-Cliffs In...
$ 7.69
-10.79